Psilocybin Clinical Trials & FDA Approval for Depression
Explore mushroom research and guides on psilocybin clinical trials & fda approval for depression.
Psilocybin Clinical Trials for Depression: 2026 Tracker
Which psilocybin trials are recruiting for depression in 2026? A complete tracker: Phase 3 programs, academic centers, eligibility, and how to enroll.
Every Major Psilocybin Depression Trial: A Complete Guide
From Hopkins 2021 to EPISODE 2026: a review of every major psilocybin depression clinical trial with actual MADRS scores, remission rates, and effect sizes.
Phase III Psilocybin Trials: What's Running Right Now
Compass has two positive Phase 3 readouts — neither peer-reviewed. Usona has closed enrollment. And the one peer-reviewed trial everyone calls Phase 3 actually missed its endpoint. Here's the real picture.
Psilocybin FDA Approval for Depression: Where Things Stand
COMPASS plans to file for psilocybin FDA approval for depression in late 2026 after two positive Phase 3 trials. Here's the evidence and what's in the way.